Amin Ladak, EPH ’01 in Health Management, Appointed Principal at Seaflower Ventures
Amin Ladak, EPH ’01 in Health Management, has been appointed Principal at Seaflower Ventures, a venture capital group focused on early-stage biomedical investing.
Prior to joining Seaflower Ventures, Amin was employed with FoldRx Pharmaceuticals, a venture-backed company in Cambridge, MA, where he was responsible for overall business management. Previously, he was Director of Venture Analysis at HealthCare Ventures, one of the world’s largest healthcare venture capital firms. He also worked at Bayer Pharmaceuticals in the New Product/New Business Development Group.
“We are very pleased to announce Amin’s appointment as a principal at Seaflower Ventures. His background and experience in investing and operating in early-stage biomedical companies further strengthens our investment team,” said Jim Sherblom, Managing General Partner of Seaflower.